CA Stock MarketDetailed Quotes

MDX Medx Health Corp

Watchlist
  • 0.060
  • -0.010-14.29%
15min DelayTrading Oct 17 11:07 ET
16.21MMarket Cap-3000P/E (TTM)

Medx Health Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
7.42%-758.32K
66.52%-455.85K
-22.18%-3.42M
35.95%-615.05K
17.36%-626.62K
-6,050.24%-819.11K
-49.38%-1.36M
37.99%-2.8M
-31.59%-960.29K
31.11%-758.29K
Net income from continuing operations
32.87%-926.41K
24.67%-926.7K
10.77%-4.58M
56.58%-601.53K
-14.82%-1.37M
-3.62%-1.38M
-0.38%-1.23M
3.57%-5.13M
8.39%-1.39M
23.25%-1.19M
Operating gains losses
----
----
---597.81K
----
----
----
----
----
----
----
Depreciation and amortization
-9.66%11.7K
-9.67%11.7K
0.27%51.83K
96.87%25.8K
-99.08%118
0.72%12.96K
0.00%12.96K
-0.23%51.69K
-9.41%13.1K
-0.66%12.86K
Remuneration paid in stock
-90.24%20.93K
25.49%64.57K
-6.55%310.03K
-91.66%6.03K
-22.46%38.14K
12.19%214.41K
168.43%51.45K
45.25%331.75K
-19.89%72.28K
116.25%49.19K
Other non cashItems
-67.96%190.1K
-61.40%176.38K
67.25%2.12M
26.41%537.93K
4.02%533.75K
96.57%593.32K
89.54%456.89K
71.71%1.27M
-28.81%425.54K
814.94%513.14K
Change In working capital
305.17%86.64K
171.16%343.59K
-112.69%-129.18K
4,836.98%87.58K
114.89%336.91K
-105.68%-42.23K
-561.19%-482.85K
2,506.75%1.02M
-99.45%1.77K
-56.35%156.78K
-Change in receivables
40.14%-69.82K
-2,111.05%-46.21K
-73.01%-129.46K
-394.08%-135.27K
464.34%127.85K
-88.79%-116.63K
91.28%-2.09K
-139.11%-74.83K
4,413.84%46K
-36.12%-35.09K
-Change in inventory
-481.22%-20.4K
42.68%-27.22K
2,845.49%155.67K
1,105.06%215.53K
14.33%-17.72K
-67.72%5.35K
-144.21%-47.48K
-1,130.91%-5.67K
121.82%17.89K
36.81%-20.69K
-Change in prepaid assets
-104.03%-784
100.34%107
-100.15%-59
-38.08%23.23K
-700.88%-11.57K
78.27%19.48K
-158.94%-31.2K
1,126.18%38.32K
1,265.74%37.52K
-95.96%1.93K
-Change in payables and accrued expense
258.34%177.64K
203.69%416.91K
-123.08%-214.01K
67.88%-74.59K
13.16%238.35K
-93.63%49.57K
-351.06%-402.08K
6,276.00%927.33K
-189.60%-232.23K
-43.07%210.64K
-Change in other working capital
----
----
-55.75%58.68K
----
----
----
----
154.44%132.61K
----
----
Interest paid (cash flow from operating activities)
35.04%-141.29K
26.08%-125.39K
-77.53%-598.35K
16.50%-73.05K
-96.27%-168.15K
---217.5K
-166.08%-169.63K
-47.89%-337.05K
---87.48K
---85.67K
Cash from discontinued investing activities
Operating cash flow
7.42%-758.32K
66.52%-455.85K
-22.18%-3.42M
35.95%-615.05K
-15.07%-626.62K
-6,050.24%-819.11K
-49.38%-1.36M
37.99%-2.8M
-31.59%-960.29K
50.53%-544.55K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
Net PPE purchase and sale
----
--0
--0
----
----
----
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
----
--0
--0
----
----
----
--0
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
208.18%829.68K
-78.51%407.8K
20.49%3.42M
-47.31%567.08K
-6.64%683.6K
62.18%269.22K
121.39%1.9M
-38.36%2.84M
662.29%1.08M
8,968.96%732.22K
Net issuance payments of debt
106.96%453.7K
-78.51%407.8K
4.90%2.95M
3.33%1.11M
-138.55%-274.54K
32.06%219.22K
121.39%1.9M
-23.27%2.82M
662.29%1.08M
8,726.71%712.22K
Net common stock issuance
--375.98K
----
--413.14K
---545K
--958.14K
--0
----
--0
--0
--0
Proceeds from stock option exercised by employees
--0
----
150.00%50K
--0
--0
--50K
----
351.67%20K
--0
--20K
Cash from discontinued financing activities
Financing cash flow
208.18%829.68K
-78.51%407.8K
20.49%3.42M
-47.31%567.08K
-6.64%683.6K
62.18%269.22K
121.39%1.9M
-38.36%2.84M
662.29%1.08M
8,968.96%732.22K
Net cash flow
Beginning cash position
-86.73%90.14K
-3.03%138.19K
33.46%142.5K
602.51%186.15K
145.72%129.17K
1,191.82%679.06K
33.46%142.5K
181.36%106.77K
-96.22%26.5K
-97.10%52.57K
Current changes in cash
112.98%71.36K
-108.95%-48.05K
-112.07%-4.31K
-141.35%-47.97K
318.61%56.99K
-4,452.49%-549.9K
1,091.65%536.56K
-48.09%35.73K
119.49%116K
97.65%-26.07K
End cash Position
25.03%161.49K
-86.73%90.14K
-3.03%138.19K
-3.03%138.19K
602.51%186.15K
219.03%129.17K
1,189.44%679.06K
33.46%142.5K
33.46%142.5K
-96.22%26.5K
Free cash from
7.42%-758.32K
66.52%-455.85K
-22.18%-3.42M
35.95%-615.05K
-15.07%-626.62K
-6,050.24%-819.11K
-49.38%-1.36M
38.22%-2.8M
-30.43%-960.29K
50.53%-544.55K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 7.42%-758.32K66.52%-455.85K-22.18%-3.42M35.95%-615.05K17.36%-626.62K-6,050.24%-819.11K-49.38%-1.36M37.99%-2.8M-31.59%-960.29K31.11%-758.29K
Net income from continuing operations 32.87%-926.41K24.67%-926.7K10.77%-4.58M56.58%-601.53K-14.82%-1.37M-3.62%-1.38M-0.38%-1.23M3.57%-5.13M8.39%-1.39M23.25%-1.19M
Operating gains losses -----------597.81K----------------------------
Depreciation and amortization -9.66%11.7K-9.67%11.7K0.27%51.83K96.87%25.8K-99.08%1180.72%12.96K0.00%12.96K-0.23%51.69K-9.41%13.1K-0.66%12.86K
Remuneration paid in stock -90.24%20.93K25.49%64.57K-6.55%310.03K-91.66%6.03K-22.46%38.14K12.19%214.41K168.43%51.45K45.25%331.75K-19.89%72.28K116.25%49.19K
Other non cashItems -67.96%190.1K-61.40%176.38K67.25%2.12M26.41%537.93K4.02%533.75K96.57%593.32K89.54%456.89K71.71%1.27M-28.81%425.54K814.94%513.14K
Change In working capital 305.17%86.64K171.16%343.59K-112.69%-129.18K4,836.98%87.58K114.89%336.91K-105.68%-42.23K-561.19%-482.85K2,506.75%1.02M-99.45%1.77K-56.35%156.78K
-Change in receivables 40.14%-69.82K-2,111.05%-46.21K-73.01%-129.46K-394.08%-135.27K464.34%127.85K-88.79%-116.63K91.28%-2.09K-139.11%-74.83K4,413.84%46K-36.12%-35.09K
-Change in inventory -481.22%-20.4K42.68%-27.22K2,845.49%155.67K1,105.06%215.53K14.33%-17.72K-67.72%5.35K-144.21%-47.48K-1,130.91%-5.67K121.82%17.89K36.81%-20.69K
-Change in prepaid assets -104.03%-784100.34%107-100.15%-59-38.08%23.23K-700.88%-11.57K78.27%19.48K-158.94%-31.2K1,126.18%38.32K1,265.74%37.52K-95.96%1.93K
-Change in payables and accrued expense 258.34%177.64K203.69%416.91K-123.08%-214.01K67.88%-74.59K13.16%238.35K-93.63%49.57K-351.06%-402.08K6,276.00%927.33K-189.60%-232.23K-43.07%210.64K
-Change in other working capital ---------55.75%58.68K----------------154.44%132.61K--------
Interest paid (cash flow from operating activities) 35.04%-141.29K26.08%-125.39K-77.53%-598.35K16.50%-73.05K-96.27%-168.15K---217.5K-166.08%-169.63K-47.89%-337.05K---87.48K---85.67K
Cash from discontinued investing activities
Operating cash flow 7.42%-758.32K66.52%-455.85K-22.18%-3.42M35.95%-615.05K-15.07%-626.62K-6,050.24%-819.11K-49.38%-1.36M37.99%-2.8M-31.59%-960.29K50.53%-544.55K
Investing cash flow
Cash flow from continuing investing activities 0000
Net PPE purchase and sale ------0--0--------------0--0--------
Cash from discontinued investing activities
Investing cash flow ------0--0--------------0--0--------
Financing cash flow
Cash flow from continuing financing activities 208.18%829.68K-78.51%407.8K20.49%3.42M-47.31%567.08K-6.64%683.6K62.18%269.22K121.39%1.9M-38.36%2.84M662.29%1.08M8,968.96%732.22K
Net issuance payments of debt 106.96%453.7K-78.51%407.8K4.90%2.95M3.33%1.11M-138.55%-274.54K32.06%219.22K121.39%1.9M-23.27%2.82M662.29%1.08M8,726.71%712.22K
Net common stock issuance --375.98K------413.14K---545K--958.14K--0------0--0--0
Proceeds from stock option exercised by employees --0----150.00%50K--0--0--50K----351.67%20K--0--20K
Cash from discontinued financing activities
Financing cash flow 208.18%829.68K-78.51%407.8K20.49%3.42M-47.31%567.08K-6.64%683.6K62.18%269.22K121.39%1.9M-38.36%2.84M662.29%1.08M8,968.96%732.22K
Net cash flow
Beginning cash position -86.73%90.14K-3.03%138.19K33.46%142.5K602.51%186.15K145.72%129.17K1,191.82%679.06K33.46%142.5K181.36%106.77K-96.22%26.5K-97.10%52.57K
Current changes in cash 112.98%71.36K-108.95%-48.05K-112.07%-4.31K-141.35%-47.97K318.61%56.99K-4,452.49%-549.9K1,091.65%536.56K-48.09%35.73K119.49%116K97.65%-26.07K
End cash Position 25.03%161.49K-86.73%90.14K-3.03%138.19K-3.03%138.19K602.51%186.15K219.03%129.17K1,189.44%679.06K33.46%142.5K33.46%142.5K-96.22%26.5K
Free cash from 7.42%-758.32K66.52%-455.85K-22.18%-3.42M35.95%-615.05K-15.07%-626.62K-6,050.24%-819.11K-49.38%-1.36M38.22%-2.8M-30.43%-960.29K50.53%-544.55K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data